🇺🇸 FDA
Pipeline program

GS-0272

GS-US-666-6692

Phase 1 small_molecule active

Quick answer

GS-0272 for Rheumatoid Arthritis is a Phase 1 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
Rheumatoid Arthritis
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials